Invadopodia formation by bladder tumor cells

Oncology Research

Volumn 19, Issue 2, 2010, Pages 85-92

  Sutoh, Mihoko ^a   Hashimoto, Yasuhiro ^a   Yoneyama, Takahiro ^b   Yamamoto, Hayato ^a   Hatakeyama, Shingo ^b   Koie, Takuya ^b   Okamoto, Akiko ^a   Yamaya, Kanemitsu ^a   Saitoh, Hisao ^a   Funyu, Tomihisa ^a   Nakamura, Toshiya ^b   Sato, Tatsusuke ^b   Ohyama, Chikara ^b   Tsuboi, Shigeru ^a,b  

^a Oyokyo Kidney Research Institute   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Bladder tumor; Invadopodia; Tumor invasion

Indexed keywords

ACTIN;

ANIMAL CELL; ARTICLE; BLADDER TUMOR; BREAST CANCER; CANCER INVASION; CONFOCAL LASER MICROSCOPY; ENZYME RELEASE; HUMAN; HUMAN CELL; INVADOPODIUM; MELANOMA; MEMBRANE STRUCTURE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

EID: 79951544145     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504010X12875107808008     Document Type: Article

References (26)

1. Jemal, A.; Tiwari, R. C.; Murray, T.; Ghafoor, A.; Samuels, A.; Ward, E.; Feuer, E. J.; Thun, M. J. Cancer statistics, 2004. CA Cancer J. Clin. 54:8-29; 2004.
2. Yamaguchi, H.; Condeelis, J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta 1773:642-652; 2007.
3. DeClerck, Y. A.; Imren, S.; Montgomery, A. M.; Mueller, B. M.; Reisfeld, R. A.; Laug, W. E. Proteases and protease inhibitors in tumor progression. Adv. Exp. Med. Biol. 425:89-97; 1997.
4. Gimona, M.; Buccione, R. Adhesions that mediate invasion. Int. J. Biochem. Cell Biol. 38:1875-1892; 2006.
5. Philippar, U.; Rousso, E. T.; Oser, M.; Yamaguchi, H.; Kim, H. D.; Giampieri, S.; Wang, Y.; Goswami, S.; Wyckoff, J. B.; Lauffenburger, D. A.; Sahai, E.; Condeelis, J. S.; Gertler, F. B. A. Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev. Cell 15:813-828; 2008.
6. Gimona, M.; Buccione, R.; Courtneidge, S. A.; Linder, S. Assembly and biological role of podosomes and invadopodia. Curr. Opin. Cell Biol. 20:235-241; 2008.
7. Monsky, W. L.; Lin, C. Y.; Aoyama, A.; Kelly, T.; Akiyama, S. K.; Mueller, S. C.; Chen, W. T. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res. 54:5702-5710; 1994.
8. Coopman, P. J.; Do, M. T.; Thompson, E. W.; Mueller, S. C. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin. Cancer Res. 4:507-515; 1998.
9. Liu, C.; Sun, C.; Huang, H.; Janda, K.; Edgington, T. Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res. 63:2957-2964; 2003.
10. Yoshio, T.; Morita, T.; Kimura, Y.; Tsujii, M.; Hayashi, N.; Sobue, K. Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation. FEBS Lett. 581:3777-3782; 2007.
11. Clark, E. S.; Whigham, A. S.; Yarbrough, W. G.; Weaver, A. M. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 67:4227-4235; 2007.
12. Desai, B.; Ma, T.; Chellaiah, M. A. Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion. J. Biol. Chem. 283:13856-13866; 2008.
13. Kelly, T.; Yan, Y.; Osborne, R. L.; Athota, A. B.; Rozypal, T. L.; Colclasure, J. C.; Chu, W. S. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases. Clin. Exp. Metastasis 16:501-512; 1998.
14. Kubota, Y.; Nakada, T.; Yanai, H.; Kakizaki, H.; Sasagawa, I.; Watanabe, M. Electropermeabilization in bladder cancer chemotherapy. Cancer Chemother. Pharmacol. 39: 67-70; 1996.
15. Hisazumi, H.; Uchibayashi, T.; Katoh, M.; Kobayashi, T.; Nakajima, K.; Naitoh, K.; Misaki, T.; Kuroda, K. Anticancer drug sensitivity in vitro in the bladder cancer cell line, KK-47 and prophylactic use of carbazilquinone and urokinase in bladder cancer. Urol. Res. 9:231-235; 1981.
16. O'Toole, C.; Perlmann, P.; Unsgaard, B.; Almgard, L. E.; Johansson, B.; Moberger, G.; Edsmyr, F. Cellular immunity to human urinary bladder carcinoma. II. EEffect of surgery and preoperative irradiation. Int. J. Cancer 10:92-98; 1972.
17. Albini, A.; Iwamoto, Y.; Kleinman, H. K.; Martin, G. R.; Aaronson, S. A.; Kozlowski, J. M.; McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239-3245; 1987.
18. Bowden, E. T.; Coopman, P. J.; Mueller, S. C. Invadopodia: Unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol. 63:613-627; 2001.
19. Chen, W. T. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool. 251:167-185; 1989.
20. Chen, W. T. Transmembrane interactions at cell adhesion and invasion sites. Cell Differ. Dev. 32:329-335; 1990.
21. Luxenburg, C.; Parsons, J. T.; Addadi, L.; Geiger, B. Involvement of the Src-cortactin pathway in podosome formation and turnover during polarization of cultured osteoclasts. J. Cell Sci. 119:4878-4888; 2006.
22. Buccione, R.; Orth, J. D.; McNiven, M. A. Foot and mouth: Podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell Biol. 5:647-657; 2004.
23. McNiven, M. A.; Baldassarre, M.; Buccione, R. The role of dynamin in the assembly and function of podosomes and invadopodia. Front. Biosci. 9:1944-1953; 2004.
24. Seals, D. F.; Azucena, Jr., E. F.; Pass, I.; Tesfay, L.; Gordon, R.; Woodrow, M.; Resau, J. H.; Courtneidge, S. A. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell 7:155-165; 2005.
25. Utz, D. C.; Farrow, G. M. Management of carcinoma in situ of the bladder: The case for surgical management. Urol. Clin. North Am. 7:533-541; 1980.
26. Millan-Rodriguez, F.; Chechile-Toniolo, G.; Salvador-Bayarri, J.; Palou, J.; Vicente-Rodriguez, J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J. Urol. 163:73-78; 2000.